COVID-19 Cases Show Device Preemption Prevails, Attorney Says
Executive Summary
Recent rulings in COVID-19 cases have produced ‘very good law’ for manufacturers wary of attempts to limit preemption, a lawyer said in a recent webinar on recent developments around device preemption.
You may also be interested in...
In Victory For Device Industry, Supreme Court Favors PMA Pre-emption
In a ruling that is expected to shave the volume of lawsuits against device manufacturers, the Supreme Court held that FDA premarket approval should preclude patients from suing companies for personal injury in most cases
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Implant
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.